[Randomized controlled clinical trials for IgA nephropathies].
Yoshikawa
Tokushige
T
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D018450:Disease Progression; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D005922:Glomerulonephritis, IGA / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D017410:Practice Guidelines as Topic; D011239:Prednisolone / Q000008:administration & dosage*; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors; D011239:Prednisolone